Australia markets closed

Janux Therapeutics, Inc. (JANX)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
41.47-1.75 (-4.05%)
At close: 04:00PM EDT
40.68 -0.79 (-1.90%)
After hours: 05:36PM EDT
Major holders
Insider roster

Insider transactions

Currency in USD
Insider purchases - Last 6 monthsSharesTrans
Purchases00
SalesN/A0
Net shares purchased (sold)00
Total insider shares held4.88MN/A
% net shares purchased (sold)N/AN/A
Net institutional purchases - Prior quarter to latest quarterShares
Net shares purchased (sold)N/A
% change in institutional shares heldN/A

Insider transactions reported - last two years

InsiderTransactionTypeValueDateShares

LICHTER JAY
Director and Beneficial Owner of more than 10% of a Class of Security

Sale at price 54.75 per share.Indirect82,125,00003 June 20241,500,000

REARDON TIGHE
Chief Financial Officer

Sale at price 54.75 per share.Indirect45,043,97503 June 2024822,721

AVALON VENTURES XI, L.P.
Beneficial Owner of more than 10% of a Class of Security

Sale at price 54.75 per share.Indirect82,125,00003 June 20241,500,000

LICHTER JAY
Director and Beneficial Owner of more than 10% of a Class of Security

Purchase at price 5.87 per share.Indirect4,988,64313 Nov 2023849,854

REARDON TIGHE
Chief Financial Officer

Purchase at price 5.87 per share.Indirect4,988,64313 Nov 2023849,854

AVALON VENTURES XI, L.P.
Beneficial Owner of more than 10% of a Class of Security

Purchase at price 5.87 per share.Indirect4,988,64313 Nov 2023849,854

RA CAPITAL MANAGEMENT, L.P.
Beneficial Owner of more than 10% of a Class of Security

Purchase at price 12.46 per share.Indirect6,167,80019 July 2023495,008

THOMPSON PETER A
Director

Sale at price 20.30 per share.Indirect820,12029 Dec 202140,400

ORBIMED ADVISORS, L.L.C.
Director

Sale at price 20.30 per share.Indirect820,12029 Dec 202140,400

THOMPSON PETER A
Director

Sale at price 19.00 per share.Indirect2,268,60021 Dec 2021119,400

THOMPSON PETER A
Director

Sale at price 19.07 per share.Indirect7,500,23116 Dec 2021393,300

ORBIMED ADVISORS, L.L.C.
Unknown

Sale at price 19.07 per share.Indirect7,500,23116 Dec 2021393,300

LICHTER JAY
Director and Beneficial Owner of more than 10% of a Class of Security

Purchase at price 17.00 per share.Indirect10,699,98715 June 2021629,411

LICHTER JAY
Director and Beneficial Owner of more than 10% of a Class of Security

Indirect15 June 20218,045,148

THOMPSON PETER A
Director

Purchase at price 17.00 per share.Indirect11,999,50115 June 2021705,853

THOMPSON PETER A
Director

Indirect15 June 20212,336,911

ORBIMED ADVISORS, L.L.C.
Beneficial Owner of more than 10% of a Class of Security

Purchase at price 17.00 per share.Indirect11,999,50115 June 2021705,853

ORBIMED ADVISORS, L.L.C.
Beneficial Owner of more than 10% of a Class of Security

Indirect15 June 20212,336,911

RA CAPITAL MANAGEMENT, L.P.
Beneficial Owner of more than 10% of a Class of Security

Purchase at price 17.00 per share.Indirect49,999,99215 June 20212,941,176

RA CAPITAL MANAGEMENT, L.P.
Beneficial Owner of more than 10% of a Class of Security

Indirect15 June 20215,729,468

REARDON TIGHE
Chief Financial Officer

Purchase at price 17.00 per share.Indirect10,699,98715 June 2021629,411

REARDON TIGHE
Chief Financial Officer

Indirect15 June 20213,850,081

AVALON VENTURES XI, L.P.
Beneficial Owner of more than 10% of a Class of Security

Purchase at price 17.00 per share.Indirect10,699,98715 June 2021629,411

AVALON VENTURES XI, L.P.
Beneficial Owner of more than 10% of a Class of Security

Indirect15 June 20218,045,148

BREGUA CORP
Beneficial Owner of more than 10% of a Class of Security

Purchase at price 17.00 per share.Indirect999,99115 June 202158,823

BREGUA CORP
Beneficial Owner of more than 10% of a Class of Security

Indirect15 June 20213,690,427